Identification of protective pneumococcal T(H)17 antigens from the soluble fraction of a killed whole cell vaccine.
about
The host immune dynamics of pneumococcal colonization: implications for novel vaccine developmentInfluenza vaccines to control influenza-associated bacterial infection: where do we stand?The oral commensal Streptococcus mitis shows a mixed memory Th cell signature that is similar to and cross-reactive with Streptococcus pneumoniae.Effect of nonheme iron-containing ferritin Dpr in the stress response and virulence of pneumococci.Protection against Streptococcus pneumoniae lung infection after nasopharyngeal colonization requires both humoral and cellular immune responsesReduced IL-17A Secretion Is Associated with High Levels of Pneumococcal Nasopharyngeal Carriage in Fijian Children.Multiple antigen-presenting system (MAPS) to induce comprehensive B- and T-cell immunity.Th17 cell based vaccines in mucosal immunity.Streptococcus pneumoniae proteomics: determinants of pathogenesis and vaccine development.Interluekin-17A (IL17A).The contrasting roles of Th17 immunity in human health and disease.Activation of memory Th17 cells by domain 4 pneumolysin in human nasopharynx-associated lymphoid tissue and its association with pneumococcal carriage.Identification of SP1683 as a pneumococcal protein that is protective against nasopharyngeal colonization.Recent approaches in whole cell pneumococcal vaccine development: a review study.Nonclassically secreted proteins as possible antigens for vaccine development: a reverse vaccinology approach.Immunodominance in T cell responses elicited against different domains of detoxified pneumolysin PlyD1.
P2860
Q28084920-DA12F28D-BF95-44C6-ADFA-5004227C4A45Q30366650-15203A12-DAAB-4437-87E0-ABAE4F90B990Q34041104-4BEF319A-B3D0-430A-A4CA-64495D61CE9BQ34298282-F606D511-2B34-4876-9EC5-DA9414E02DAEQ35154329-C0878D5B-6BD8-4F25-BA0C-A50E30C4BE8DQ35662232-9469B110-C787-40AC-8720-883A0F090161Q37103959-9BB2421D-F308-4296-A45C-D4E0109A650AQ38106558-6E6B3AC4-9293-4FF5-A8FF-C7D110792F0BQ38622377-008FAC04-0154-49F0-817F-58F1E39C7E8DQ39103136-5A76ED06-0F97-4E03-97D5-752BCD3C1ACFQ39146450-8E627BAE-DE07-4A4B-B384-AEB0A91BA2FAQ43519933-6CAE9A44-4E5C-4CCE-8CE3-870992698024Q50199957-AEBFF00C-9690-4CD6-AF14-491C9BDDFDA5Q50305151-4A35FF41-2A8A-4AA1-8304-DF10F5A93CD3Q51009284-433BFB40-AA17-41B5-8855-65A600F94000Q52365761-CA694A7B-8088-409F-A2FF-A834DD8A03A2
P2860
Identification of protective pneumococcal T(H)17 antigens from the soluble fraction of a killed whole cell vaccine.
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Identification of protective pneumococcal T
@nl
Identification of protective p ...... f a killed whole cell vaccine.
@ast
Identification of protective p ...... f a killed whole cell vaccine.
@en
type
label
Identification of protective pneumococcal T
@nl
Identification of protective p ...... f a killed whole cell vaccine.
@ast
Identification of protective p ...... f a killed whole cell vaccine.
@en
prefLabel
Identification of protective pneumococcal T
@nl
Identification of protective p ...... f a killed whole cell vaccine.
@ast
Identification of protective p ...... f a killed whole cell vaccine.
@en
P2093
P2860
P1433
P1476
Identification of protective p ...... f a killed whole cell vaccine.
@en
P2093
Kristin L Moffitt
Richard Malley
Ying-Jie Lu
P2860
P304
P356
10.1371/JOURNAL.PONE.0043445
P407
P577
2012-08-14T00:00:00Z